Company Name: |
Shanghai Chaolan Chemical Technology Center
|
Tel: |
QQ:65489617 15618227136 |
Email: |
info@SuperLan-chem.com |
Products Intro: |
Product Name:RORγt inverse agonist 13 CAS:2170477-75-3 Purity:98% Package:5MG;10MG;50MG;100MG,1G,5G,100G
|
Company Name: |
Shanghai Dongyang Biotechnology Co., Ltd.
|
Tel: |
0512-0512-13601744364 13601744364 |
Email: |
chemsharker@126.com |
Products Intro: |
Product Name:RORγt inverse agonist 13 CAS:2170477-75-3 Purity:98% Package:1g 5g 10g 25g 50g 100g
|
Company Name: |
TargetMol Chemicals Inc.
|
Tel: |
4008200310 |
Email: |
marketing@tsbiochem.com |
Products Intro: |
Product Name:RORγt inverse agonist 13 CAS:2170477-75-3 Purity:99% Package:1mg/RMB 495;5mg/RMB 1180;10mg/RMB 1950
|
|
| Benzeneacetic acid, 4-[[[[[2,6-dichloro-2'-(trifluoromethoxy)[1,1'-biphenyl]-4-yl]amino]carbonyl]amino]methyl]- Basic information |
Product Name: | Benzeneacetic acid, 4-[[[[[2,6-dichloro-2'-(trifluoromethoxy)[1,1'-biphenyl]-4-yl]amino]carbonyl]amino]methyl]- | Synonyms: | Benzeneacetic acid, 4-[[[[[2,6-dichloro-2'-(trifluoromethoxy)[1,1'-biphenyl]-4-yl]amino]carbonyl]amino]methyl]-;RORγt inverse agonist 13;RORγt inverse agonist 13,ROR,RORγt inverse agonist-13,RAR-related orphan receptor,inhibit,RORγt inverse agonist13,Inhibitor;Benzeneacetic acid, 4-[[[[[2,6-dichloro-2'-(trifluoromethoxy)[1,1'-biphenyl]-4-yl]amino]carbonyl]amino]methyl]- | CAS: | 2170477-75-3 | MF: | C23H17Cl2F3N2O4 | MW: | 513.29 | EINECS: | | Product Categories: | | Mol File: | 2170477-75-3.mol | |
| Benzeneacetic acid, 4-[[[[[2,6-dichloro-2'-(trifluoromethoxy)[1,1'-biphenyl]-4-yl]amino]carbonyl]amino]methyl]- Chemical Properties |
Boiling point | 552.9±50.0 °C(Predicted) | density | 1.470±0.06 g/cm3(Predicted) | storage temp. | Store at -20°C | solubility | DMSO : 100 mg/mL (194.82 mM; Need ultrasonic) | pka | 4.30±0.10(Predicted) | form | Solid | color | White to off-white |
| Benzeneacetic acid, 4-[[[[[2,6-dichloro-2'-(trifluoromethoxy)[1,1'-biphenyl]-4-yl]amino]carbonyl]amino]methyl]- Usage And Synthesis |
Biological Activity | RORγt inverse agonist 13 (Compound 3i) is a potent, orally active and selective RORγt inverse agonist, with improved drug-like properties, with an IC50 of 63.8 nM[1].
RORγt inverse agonist 13 (Compound 3i) exhibits activity with an inhibition of 76% at 0.3 μM in Th17 cell differentiation assay[1].
RORγt inverse agonist 13 (Compound 3i, 25 mg/kg, Orally, twice daily) demonstrats excellent in vivo PK profile in mice and good in vivo efficacy in an IMQ-induced psoriasis mice model[1]. | References | [1]. Nannan Sun, et al. Discovery of carboxyl-containing biaryl ureas as potent RORγt inverse agonists. Eur J Med Chem. 2020 Jul 5;202:112536. |
| Benzeneacetic acid, 4-[[[[[2,6-dichloro-2'-(trifluoromethoxy)[1,1'-biphenyl]-4-yl]amino]carbonyl]amino]methyl]- Preparation Products And Raw materials |
|